What is it?
Cefixime is a third-generation cephalosporin antibiotic. It is a prescription-only medication used to treat a wide variety of bacterial infections by stopping the growth of bacteria.
Important Note: This medication is only effective against bacterial infections. It will not work for viral infections like the common cold or flu.
Primary Uses
Cefixime 200 mg is commonly prescribed to treat:
-
Respiratory Tract Infections: Such as bronchitis, tonsillitis, and pharyngitis.
-
Ear Infections: Otitis media.
-
Urinary Tract Infections (UTIs): Uncomplicated infections of the bladder or kidneys.
-
Sexually Transmitted Infections: Uncomplicated gonorrhea.
-
Typhoid Fever: Often used as an alternative oral treatment option.
Side Effects
While generally well-tolerated, some individuals may experience side effects.
Common Side Effects:
- Diarrhea or loose stools
- Nausea or vomiting
- Stomach pain or indigestion
- Dizziness or headache
Severe Side Effects :
-
Severe, persistent diarrhea with cramping or blood (a sign of C. difficile infection)
-
Signs of an allergic reaction (skin rash, itching, swelling of the face/tongue/throat, severe dizziness, trouble breathing)
-
Yellowing eyes or skin (jaundice) or dark urine
Precautions & Warnings
-
Complete the Course: Always finish the entire prescribed dosage, even if symptoms disappear after a few days. Stopping early may allow the bacteria to return and develop resistance.
-
Allergies: Inform your doctor if you are allergic to penicillin or other cephalosporin antibiotics, as cross-reactivity can occur.
-
Medical History: Share your medical history with your healthcare provider, especially if you have kidney disease or a history of severe intestinal diseases (like colitis).
-
Pregnancy and Breastfeeding: Consult your doctor before using this medication if you are pregnant, planning to become pregnant, or breastfeeding.
-
Alcohol: It is best to avoid alcohol while taking antibiotics to minimize gastrointestinal side effects and dehydration.
Reviews
There are no reviews yet.